Ma, Q., Wang, S., Xue, H., Ni, L., Yuan, P., Shen, Y., . . . Jie, Z. Targeting Msx2 as a brake in the fusion fate of osteoclasts and an anabolic therapy in pre-clinical models of osteoporosis. Nature Portfolio.
Chicago Style (17th ed.) CitationMa, Qingliang, et al. Targeting Msx2 as a Brake in the Fusion Fate of Osteoclasts and an Anabolic Therapy in Pre-clinical Models of Osteoporosis. Nature Portfolio.
MLA (9th ed.) CitationMa, Qingliang, et al. Targeting Msx2 as a Brake in the Fusion Fate of Osteoclasts and an Anabolic Therapy in Pre-clinical Models of Osteoporosis. Nature Portfolio.
Warning: These citations may not always be 100% accurate.